U.S. Uterine Fibroid Market New Discoveries in Drug and Devices Market Till 2022Posted by Rohit Kamble on January 28th, 2020 U.S. Uterine Fibroid Market Information by Type (Subserosal Fibroids, Intramural Fibroids, Submucosal Fibroids and others), by Diagnosis (Medical Resonance Imaging (MRI) scanners, Computed Tomography (CT), Ultrasounds and others) and Treatment (Uterine Fibroid Embolization, Magnetic Resonance Guided Focused Ultrasound, Myolysis, Endometrial Ablation, Hysterectomy and Myomectomy) - Forecast to 2022 The U.S. Uterine Fibroid Market report offers insights into the leading market players and presents an assessment of their current market position. Company information with regards to revenue, segmental share, geographical income, SWOT, growth strategies, new product launch, M&A activities, and the latest R&D initiatives is also available in the report Major Key Players To gain a substantially large competitive advantage, these players incorporate strategic initiatives such as mergers & acquisitions, collaboration, expansion, and product launch. Due to the increasing strategic partnerships, the structure of the market is changing rapidly. Besides, the growing competition in the market is encouraging multinational companies to acquire small yet promising companies operating in the developing markets. AstraZeneca (England), Cook Medical Inc. (US), Boston Scientific Corporation (US), GE Healthcare (U.K.), AbbVie Inc. (U.S.), Hologic (U.S.), and others. Market Segment Analysis The United States Uterine Fibroid market is showing the significant growth; mainly due to change in lifestyle mainly dietary pattern, growing number of hysterectomy surgeries. Additionally rising in aging population also leads the Uterine Fibroid market with in this region. According to U.S. Department of Health and Human Services, study found that before 50s 70% of white and 80% of African Americans are diagnosed with fibroids. Also more than 200,000 hysterectomies are performed each year for uterine fibroids. Hysterectomies is the surgery that is used to remove the uterus, if the condition is painful. Increasing incidence of uterine fibroid United States generate the interest of companies toward the market of uterine fibroid, as they feel there are huge opportunities and gaps between the market demand and supply of quality devices. Thus, companies are showing more interest in research and development activities for introducing the advanced treatment that meets the requirement of market. For instant, in Feb 2017, AstraZeneca has entered into an agreement with TerSera Therapeutics LLC (TerSera) for the commercial rights to Zoladex (goserelin acetate implant) in the US and Canada. Zoladex is an injectable luteinising hormone-releasing hormone agonist, used to treat prostate cancer, breast cancer and certain benign gynaecological disorders. Moreover, in Nov 2016, Boston Scientific Corporation Acquires Resectr Tissue Resection Device from Distal Access, LLC. The portfolio includes the Resectr Tissue Resection Device, a single-use solution designed to effectively remove uterine polyps. The companies are introducing better devices for getting the leadership in the Uterine Fibroid devices market. Additionally company are focusing more into research and development activity in order to launch advanced device for the treatment of uterine fibroid. In this regard, GE today announced the launch of the Optima MR430s, a new specialty scanner with breakthrough technology that delivers precise imaging with exceptional com Top of Form Key Study Highlights:
Regional Analysis Geographically, the global U.S. Uterine Fibroid Market has been divided into the Americas, Europe, Asia-Pacific, and the Middle East and Africa. Browse Full Report Page Enabled with complete Table of Content at https://www.marketresearchfuture.com/reports/uterine-fibroid-market-2394 Chapter 9. Global U.S. Uterine Fibroid Market By Region 9.1 Introduction 9.2 America 9.2.1 North America 9.2.1.1 U.S. 9.2.1.2 Canada 9.2.2 South America 9.3 Europe 9.3.1 Western Europe 9.3.1.1 Germany 9.3.1.2 France 9.3.1.3 Italy 9.3.1.4 Spain 9.3.1.5 U.K. 9.3.1.6 Rest Of Western Europe 9.3.2 Eastern Europe 9.4 Asia Pacific 9.4.1 Japan 9.4.2 China 9.4.3 India 9.4.4 Australia 9.4.5 Republic Of Korea 9.4.6 Rest Of Asia Pacific 9.5 The Middle East & Africa 9.5.1 United Arab Emirates 9.5.2 Saudi Arabia 9.5.3 Oman 9.5.4 Kuwait 9.5.5 Qatar 9.5.6 Rest Of The Middle East & Africa About Market Research Future: MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members. Contact: +1 646 845 9312 | Email: sales@marketresearchfuture.com Like it? Share it!More by this author |